Guangzhou Laboratory, Guangzhou, 510005, China.
Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
Sci Rep. 2023 Apr 17;13(1):6267. doi: 10.1038/s41598-023-33452-0.
In order to realize the application of the nasal spray vaccination in the prevention and protection of respiratory infectious diseases, a nasal spray vaccination device is designed in this paper. The device uses a Laval nozzle structure to generate a high-speed airflow that impinges on the vaccine reagent and forms nebulized particles. Through optimizing of the Laval nozzle structure and testing experiments on spray particle size, spray velocity, spray angle and spray rate, a set of parameters which is applicable to actual nasal spray vaccination is obtained. The experimental results show that when the air source pressure is 2 bar, the spray angle is about 15°, the diameter of the spray particles Dv50 is about 17 μm, the volume fraction of particles with diameter smaller than 10um is about 24%, the spray rate is close to 300 μl/s. The vaccine activity tests demonstrate that under these conditions, not only the biological activity of vaccines is guaranteed, but also the delivery efficiency is well assured.
为了实现鼻腔喷雾接种在预防和保护呼吸道传染病中的应用,本文设计了一种鼻腔喷雾接种装置。该装置采用拉瓦尔喷嘴结构产生高速气流,冲击疫苗试剂,形成雾化颗粒。通过对拉瓦尔喷嘴结构的优化和喷雾粒径、喷雾速度、喷雾角度和喷雾速率的测试实验,获得了一套适用于实际鼻腔喷雾接种的参数。实验结果表明,当气源压力为 2 巴时,喷雾角度约为 15°,喷雾颗粒的直径 Dv50 约为 17μm,直径小于 10μm 的颗粒体积分数约为 24%,喷雾速率接近 300μl/s。疫苗活性测试表明,在这些条件下,不仅保证了疫苗的生物活性,而且保证了良好的输送效率。